Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 11
Phase 21
Phase 41

Trial Status

Completed1
Recruiting2
Other1

Role Distribution

Principal Investigator4
PI Rate100%

Activity Timeline

Clinical Trials (4)

NCT06676033Phase 1Active Not Recruiting
Epcoritamab in Chronic Lymphocytic Leukemia and Richter Syndrome
Leukemia, Chronic LymphocyticRichter Syndrome
PrincipalinvestigatorStart date: 2025-07-18
NCT05170399Phase 4Recruiting
Vaccine Responses in Patients With B Cell Malignancies
Lymphoma
PrincipalinvestigatorStart date: 2022-09-14
NCT03204188Phase 2Completed
Ibrutinib, Fludarabine, and Pembrolizumab in High-Risk or Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
B-Cell Chronic Lymphocytic LeukemiaB-Lymphocytic Leukemia, ChronicChronic Lymphocytic Leukemia+6 more
PrincipalinvestigatorStart date: 2017-09-22

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Jae Park, MD

Memorial Sloan Kettering Cancer Center

Related
17 trials

Shared therapeutic areas:

Leukemia, Lymphocytic, Chronic, B-CellWaldenstrom Macroglobulinemia

Worked with same sponsors:

National Heart, Lung, and Blood Institute (NHLBI)
Similarity Score9%

Hagop Youssoufian, MD

Verastem, Inc.

Related
20 trials

Shared therapeutic areas:

Leukemia, Lymphocytic, Chronic, B-CellLymphoma
Similarity Score9%

Mary Horowitz, MD

Center for International Blood and Marrow Transplant Research

Related
24 trials

Shared therapeutic areas:

LymphomaLeukemia, Lymphocytic, Chronic, B-Cell

Worked with same sponsors:

National Heart, Lung, and Blood Institute (NHLBI)
Similarity Score9%

Arnon Nagler, MD

Chaim Sheba Medical Center

Related
12 trials

Shared therapeutic areas:

Leukemia, Lymphocytic, Chronic, B-CellLymphoma
Similarity Score9%

Farhad Ravandi, MD

M.D. Anderson Cancer Center

Related
2 trials

Shared therapeutic areas:

Leukemia, Lymphocytic, Chronic, B-CellLymphoma
Similarity Score9%

Helen Heslop, MD

Baylor College of Medicine

Related
17 trials

Shared therapeutic areas:

Leukemia, Lymphocytic, Chronic, B-CellLymphoma

Worked with same sponsors:

National Heart, Lung, and Blood Institute (NHLBI)
Similarity Score9%

Michael B Gill

Power Life Sciences Inc.

Related
105 trials

Shared therapeutic areas:

Leukemia, Lymphocytic, Chronic, B-CellLymphoma
Similarity Score9%

David Avigan, MD

Beth Israel Deaconess Medical Center

Related
17 trials

Shared therapeutic areas:

Leukemia, Lymphocytic, Chronic, B-CellLymphoma

Worked with same sponsors:

National Heart, Lung, and Blood Institute (NHLBI)
Similarity Score9%

Vincenzo Liso, MD

UO Universita degi Studi Policinico Ematologia

Related
1 trials

Shared therapeutic areas:

Lymphoma
Similarity Score4%

Beata Holkova, MD

Massey Cancer Center

Related
3 trials

Shared therapeutic areas:

Lymphoma
Similarity Score4%

Publications (0)

No publications found for this investigator.

Clinical Trials (4)

Showing 4 of 4 trials

NCT06676033Phase 1PrincipalInvestigator

Epcoritamab in Chronic Lymphocytic Leukemia and Richter Syndrome

Leukemia, Chronic LymphocyticRichter Syndrome
Active Not Recruiting
NCT05170399Phase 4PrincipalInvestigator

Vaccine Responses in Patients With B Cell Malignancies

Lymphoma
Recruiting
NCT03204188Phase 2PrincipalInvestigator

Ibrutinib, Fludarabine, and Pembrolizumab in High-Risk or Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

B-Cell Chronic Lymphocytic LeukemiaB-Lymphocytic Leukemia, ChronicChronic Lymphocytic Leukemia+6 more
Completed
NCT00923507PrincipalInvestigator

Natural History Study of Monoclonal B Cell Lymphocytosis (MBL), Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL), Lymphoplasmacytic Lymphoma (LPL)/Waldenstrom Macroglobulinemia (WM), and Splenic Marginal Zone Lymphoma (SMZL)

CLL (Chronic Lymphocytic Leukemia)Lymphoplasmacytic LymphomaMonoclonal B-Cell Lymphocytosis+2 more
Recruiting

All 4 trials loaded